InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,942.08
(
1.04%
)
Post# of 2042
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Ortiz

Send PM Follow Ignore
Followers 6
Posts 394
Boards Moderated 0
Alias Born 10/07/2015

Ortiz

Re: midastouch017 post# 1920

Tuesday, 08/23/2022 8:53:57 AM

Tuesday, August 23, 2022 8:53:57 AM

Post# of 2042
I, as well, have invested in this up and coming biotech. It’s molecule is a first in class adenosine receptor agonist. Side effects are minimal compared to other classes of drugs intended to treat psoriasis.

Potentially, the drug could become first in line due to its safety profile.

If company fails I will consider it my contribution to the advancement of science.

Not a financial advisor, but I am comfortably parked here for a long time. I can see 2-3 years out, if we survive. Hopefully, indication for psoriasis in canines comes first, which I don’t expect to fail, providing much needed funds.

IMO

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CANF News
More CANF News
InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!